|
Arreno Cap (Aspirin and Dipyridamole)(India)
200/25 mg / 30 caps
$59.00
|
200/25 mg / 30 caps | 30 caps | $59.00 | Buy |
|
Arreno Cap (Aspirin and Dipyridamole)(India)
200/25 mg / 60 caps
$69.00
|
200/25 mg / 60 caps | 60 caps | $69.00 | Buy |
|
Arreno Cap (Aspirin and Dipyridamole)(India)
200/25 mg / 90 caps
$79.00
|
200/25 mg / 90 caps | 90 caps | $79.00 | Buy |
Arreno Cap combines Aspirin and Dipyridamole, two powerful antiplatelet agents, to reduce the risk of stroke and blood clot formation. This combination is particularly beneficial for individuals with a history of blood clots or cardiovascular events, helping to prevent clot recurrence by inhibiting platelet aggregation.
Arreno Cap is an effective antiplatelet therapy designed to help prevent strokes and reduce the formation of blood clots in patients with a history of transient ischemic attacks (TIAs) or previous strokes. By combining the blood-thinning effects of Aspirin with the platelet-inhibiting properties of Dipyridamole, Arreno Cap effectively lowers the risk of clot-related complications and promotes long-term cardiovascular health.
Aspirin works by inhibiting enzymes that lead to clot formation, while Dipyridamole prevents platelets from sticking together. This dual-action approach is particularly useful for individuals with conditions that put them at higher risk for blood clots or recurrent strokes. Regular use of Arreno Cap under medical supervision helps ensure that patients receive effective antiplatelet therapy without the need for complex monitoring. However, as with all anticoagulant or antiplatelet treatments, it’s important for patients to follow prescribed guidance to minimize potential side effects and maximize therapeutic benefits.
| Quick Links | |
| Policies | |
| Customer Service |
Copyright © 2017 - 2024
